Fate Therapeutics (FATE) names Matthew Abernethy to Board
Go back to Fate Therapeutics (FATE) names Matthew Abernethy to Board| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.45 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.45 | 52 Week High | $4.76 | |||
| Open | $2.45 | 52 Week Low | $1.46 | |||
| Day High | $2.51 | P/E | N/A | |||
| Day Low | $2.42 | EPS | $-1.91 | |||
| Volume | 114,935 | |||||
| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 157.28 -0.51 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $157.79 | 52 Week High | $58.46 | |||
| Open | $159.93 | 52 Week Low | $31.25 | |||
| Day High | $159.93 | P/E | N/A | |||
| Day Low | $156.76 | EPS | $-0.69 | |||
| Volume | 122,511 | |||||
